Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
149.13
+6.60 (4.63%)
At close: Dec 16, 2025, 4:00 PM EST
149.13
0.00 (0.00%)
After-hours: Dec 16, 2025, 4:00 PM EST
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $5.56 billion as of December 16, 2025. Its market cap has increased by 167.01% in one year.
Market Cap
5.56B
Enterprise Value
5.14B
1-Year Change
167.01%
Ranking
Category
Stock Price
$149.13
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $5.56B, an increase of 3,746.13%. That is a compound annual growth rate of 173.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 5.35B | 174.42% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |